Sofinnova Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sofinnova Investments’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,762	Closed	-$11.6M	–	80
2020 Q4	$11.6M	Buy	100,762 +17,818	+21%	+$2M	0.69%	29
2020 Q3	$8.07M	Buy	+82,944	New	+$9.55M	0.6%	28
2019 Q2	–	Sell	-20,000	Closed	-$3.37M	–	88
2019 Q1	$3.37M	Sell	20,000 -10,000	-33%	-$1.49M	0.32%	48
2018 Q4	$2.92M	Buy	+30,000	New	+$3.94M	0.36%	49
2018 Q3	–	Sell	-63,070	Closed	-$8.8M	–	70
2018 Q2	$8.8M	Buy	63,070 +59,433	+1,634%	+$8.44M	1%	24
2018 Q1	$410K	Buy	+3,637	New	+$457K	0.07%	32

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sofinnova Investments's GWPH Position: Q1 2021 in Review

Sofinnova Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 100,762 shares — an estimated $11.6M sold.

Sofinnova Investments first reported a position in GWPH in Q1 2018 and held it in 6 quarters. The position peaked at $11.6M in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Sofinnova Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Sofinnova Investments sold 100,762 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $11.6M.
Sofinnova Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 6 quarters.
Sofinnova Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11.6M in Q4 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Sofinnova Investments's 13F filing for Q1 2021, filed 14 May 2021.